S-nitrosylation of Cdk5

References

• Lew J, Huang QQ, Qi Z, Winkfein RJ, Aebersold R, Hunt T, et al. A brain-specific activator of cyclin-dependent kinase 5. Nature 1994; 371:423 - 6; http://dx.doi.org/10.1038/371423a0; PMID: 8090222
   PubMed Web of Science ®Google Scholar
• Tang D, Yeung J, Lee KY, Matsushita M, Matsui H, Tomizawa K, et al. An isoform of the neuronal cyclin-dependent kinase 5 (Cdk5) activator. J Biol Chem 1995; 270:26897 - 903; http://dx.doi.org/10.1074/jbc.270.45.26897; PMID: 7592934
   PubMed Web of Science ®Google Scholar
• Tsai LH, Lee MS, Cruz J. Cdk5, a therapeutic target for Alzheimer's disease?. Biochim Biophys Acta 2004; 1697:137 - 142
   PubMed Web of Science ®Google Scholar
• Kim Y, Sung JY, Ceglia I, Lee KW, Ahn JH, Halford JM, et al. Phosphorylation of WAVE1 regulates actin polymerization and dendritic spine morphology. Nature 2006; 442:814 - 7; http://dx.doi.org/10.1038/nature04976; PMID: 16862120
   PubMed Web of Science ®Google Scholar
• Ohshima T, Ward JM, Huh CG, Longenecker G, Veeranna, Pant HC, et al. Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc Natl Acad Sci U S A 1996; 93:11173 - 8; http://dx.doi.org/10.1073/pnas.93.20.11173; PMID: 8855328
   PubMed Web of Science ®Google Scholar
• Xie Z, Sanada K, Samuels BA, Shih H, Tsai LH. Serine 732 phosphorylation of FAK by Cdk5 is important for microtubule organization, nuclear movement, and neuronal migration. Cell 2003; 114:469 - 82; http://dx.doi.org/10.1016/S0092-8674(03)00605-6; PMID: 12941275
   PubMed Web of Science ®Google Scholar
• Patrick C, Crews L, Desplats P, Dumaop W, Rockenstein E, Achim CL, et al. Increased CDK5 expression in HIV encephalitis contributes to neurodegeneration via tau phosphorylation and is reversed with Roscovitine. Am J Pathol 2011; 178:1646 - 61; http://dx.doi.org/10.1016/j.ajpath.2010.12.033; PMID: 21435449
   PubMed Web of Science ®Google Scholar
• Nguyen MD, Larivière RC, Julien JP. Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions. Neuron 2001; 30:135 - 47; http://dx.doi.org/10.1016/S0896-6273(01)00268-9; PMID: 11343650
   PubMed Web of Science ®Google Scholar
• Paoletti P, Vila I, Rifé M, Lizcano JM, Alberch J, Ginés S. Dopaminergic and glutamatergic signaling crosstalk in Huntington’s disease neurodegeneration: the role of p25/cyclin-dependent kinase 5. J Neurosci 2008; 28:10090 - 101; http://dx.doi.org/10.1523/JNEUROSCI.3237-08.2008; PMID: 18829967
   PubMed Web of Science ®Google Scholar
• Patrick GN, Zukerberg L, Nikolic M, de la Monte S, Dikkes P, Tsai LH. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 1999; 402:615 - 22; http://dx.doi.org/10.1038/45159; PMID: 10604467
   PubMed Web of Science ®Google Scholar
• Qu D, Rashidian J, Mount MP, Aleyasin H, Parsanejad M, Lira A, et al. Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson’s disease. Neuron 2007; 55:37 - 52; http://dx.doi.org/10.1016/j.neuron.2007.05.033; PMID: 17610816
   PubMed Web of Science ®Google Scholar
• Smith PD, Crocker SJ, Jackson-Lewis V, Jordan-Sciutto KL, Hayley S, Mount MP, et al. Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson’s disease. Proc Natl Acad Sci U S A 2003; 100:13650 - 5; http://dx.doi.org/10.1073/pnas.2232515100; PMID: 14595022
   PubMed Web of Science ®Google Scholar
• Wang J, Liu S, Fu Y, Wang JH, Lu Y. Cdk5 activation induces hippocampal CA1 cell death by directly phosphorylating NMDA receptors. Nat Neurosci 2003; 6:1039 - 47; http://dx.doi.org/10.1038/nn1119; PMID: 14502288
   PubMed Web of Science ®Google Scholar
• Kitazawa M, Oddo S, Yamasaki TR, Green KN, LaFerla FM. Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer’s disease. J Neurosci 2005; 25:8843 - 53; http://dx.doi.org/10.1523/JNEUROSCI.2868-05.2005; PMID: 16192374
   PubMed Web of Science ®Google Scholar
• Lee MS, Kwon YT, Li M, Peng J, Friedlander RM, Tsai LH. Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 2000; 405:360 - 4; http://dx.doi.org/10.1038/35012636; PMID: 10830966
   PubMed Web of Science ®Google Scholar
• Sahlgren CM, Pallari HM, He T, Chou YH, Goldman RD, Eriksson JE. A nestin scaffold links Cdk5/p35 signaling to oxidant-induced cell death. EMBO J 2006; 25:4808 - 19; http://dx.doi.org/10.1038/sj.emboj.7601366; PMID: 17036052
   PubMed Web of Science ®Google Scholar
• Strocchi P, Pession A, Dozza B. Up-regulation of cDK5/p35 by oxidative stress in human neuroblastoma IMR-32 cells. J Cell Biochem 2003; 88:758 - 65; http://dx.doi.org/10.1002/jcb.10391; PMID: 12577309
   PubMed Web of Science ®Google Scholar
• Zambrano CA, Egaña JT, Núñez MT, Maccioni RB, González-Billault C. Oxidative stress promotes tau dephosphorylation in neuronal cells: the roles of cdk5 and PP1. Free Radic Biol Med 2004; 36:1393 - 402; http://dx.doi.org/10.1016/j.freeradbiomed.2004.03.007; PMID: 15135175
   PubMed Web of Science ®Google Scholar
• Cruz JC, Kim D, Moy LY, Dobbin MM, Sun X, Bronson RT, et al. p25/cyclin-dependent kinase 5 induces production and intraneuronal accumulation of amyloid beta in vivo. J Neurosci 2006; 26:10536 - 41; http://dx.doi.org/10.1523/JNEUROSCI.3133-06.2006; PMID: 17035538
   PubMed Web of Science ®Google Scholar
• Cruz JC, Tseng HC, Goldman JA, Shih H, Tsai LH. Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 2003; 40:471 - 83; http://dx.doi.org/10.1016/S0896-6273(03)00627-5; PMID: 14642273
   PubMed Web of Science ®Google Scholar
• Otth C, Concha II, Arendt T, Stieler J, Schliebs R, González-Billault C, et al. AbetaPP induces cdk5-dependent tau hyperphosphorylation in transgenic mice Tg2576. J Alzheimers Dis 2002; 4:417 - 30; PMID: 12446973
   PubMedGoogle Scholar
• Iijima K, Ando K, Takeda S, Satoh Y, Seki T, Itohara S, et al. Neuron-specific phosphorylation of Alzheimer’s beta-amyloid precursor protein by cyclin-dependent kinase 5. J Neurochem 2000; 75:1085 - 91; http://dx.doi.org/10.1046/j.1471-4159.2000.0751085.x; PMID: 10936190
   PubMed Web of Science ®Google Scholar
• Fischer A, Sananbenesi F, Pang PT, Lu B, Tsai LH. Opposing roles of transient and prolonged expression of p25 in synaptic plasticity and hippocampus-dependent memory. Neuron 2005; 48:825 - 38; http://dx.doi.org/10.1016/j.neuron.2005.10.033; PMID: 16337919
   PubMed Web of Science ®Google Scholar
• Nakamura T, Lipton SA. S-Nitrosylation and uncompetitive/fast off-rate (UFO) drug therapy in neurodegenerative disorders of protein misfolding. Cell Death Differ 2007; 14:1305 - 14; http://dx.doi.org/10.1038/sj.cdd.4402138; PMID: 17431424
   PubMed Web of Science ®Google Scholar
• Abu-Soud HM, Stuehr DJ. Nitric oxide synthases reveal a role for calmodulin in controlling electron transfer. Proc Natl Acad Sci U S A 1993; 90:10769 - 72; http://dx.doi.org/10.1073/pnas.90.22.10769; PMID: 7504282
   PubMed Web of Science ®Google Scholar
• Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 1991; 351:714 - 8; http://dx.doi.org/10.1038/351714a0; PMID: 1712077
   PubMed Web of Science ®Google Scholar
• Sattler R, Xiong Z, Lu WY, Hafner M, MacDonald JF, Tymianski M. Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein. Science 1999; 284:1845 - 8; http://dx.doi.org/10.1126/science.284.5421.1845; PMID: 10364559
   PubMed Web of Science ®Google Scholar
• Kim E, Sheng M. PDZ domain proteins of synapses. Nat Rev Neurosci 2004; 5:771 - 81; http://dx.doi.org/10.1038/nrn1517; PMID: 15378037
   PubMed Web of Science ®Google Scholar
• Lipton SA, Choi YB, Pan ZH, Lei SZ, Chen HS, Sucher NJ, et al. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 1993; 364:626 - 32; http://dx.doi.org/10.1038/364626a0; PMID: 8394509
   PubMed Web of Science ®Google Scholar
• Cho DH, Nakamura T, Fang J, Cieplak P, Godzik A, Gu Z, et al. S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury. Science 2009; 324:102 - 5; http://dx.doi.org/10.1126/science.1171091; PMID: 19342591
   PubMed Web of Science ®Google Scholar
• Chung KK, Thomas B, Li X, Pletnikova O, Troncoso JC, Marsh L, et al. S-nitrosylation of parkin regulates ubiquitination and compromises parkin’s protective function. Science 2004; 304:1328 - 31; http://dx.doi.org/10.1126/science.1093891; PMID: 15105460
   PubMed Web of Science ®Google Scholar
• Uehara T, Nakamura T, Yao D, Shi ZQ, Gu Z, Ma Y, et al. S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature 2006; 441:513 - 7; http://dx.doi.org/10.1038/nature04782; PMID: 16724068
   PubMed Web of Science ®Google Scholar
• Yao D, Gu Z, Nakamura T, Shi ZQ, Ma Y, Gaston B, et al. Nitrosative stress linked to sporadic Parkinson’s disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity. Proc Natl Acad Sci U S A 2004; 101:10810 - 4; http://dx.doi.org/10.1073/pnas.0404161101; PMID: 15252205
   PubMed Web of Science ®Google Scholar
• Qu J, Nakamura T, Cao G, Holland EA, McKercher SR, Lipton SA. S-Nitrosylation activates Cdk5 and contributes to synaptic spine loss induced by β-amyloid peptide. Proc Natl Acad Sci U S A 2011; 108:14330 - 5; http://dx.doi.org/10.1073/pnas.1105172108; PMID: 21844361
   PubMed Web of Science ®Google Scholar
• Tian B, Yang Q, Mao Z. Phosphorylation of ATM by Cdk5 mediates DNA damage signalling and regulates neuronal death. Nat Cell Biol 2009; 11:211 - 8; http://dx.doi.org/10.1038/ncb1829; PMID: 19151707
   PubMed Web of Science ®Google Scholar
• Ho GP, Selvakumar B, Mukai J, Hester LD, Wang Y, Gogos JA, et al. S-nitrosylation and S-palmitoylation reciprocally regulate synaptic targeting of PSD-95. Neuron 2011; 71:131 - 41; http://dx.doi.org/10.1016/j.neuron.2011.05.033; PMID: 21745643
   PubMed Web of Science ®Google Scholar
• Asada A, Yamamoto N, Gohda M, Saito T, Hayashi N, Hisanaga S. Myristoylation of p39 and p35 is a determinant of cytoplasmic or nuclear localization of active cyclin-dependent kinase 5 complexes. J Neurochem 2008; 106:1325 - 36; http://dx.doi.org/10.1111/j.1471-4159.2008.05500.x; PMID: 18507738
   PubMed Web of Science ®Google Scholar
• Morabito MA, Sheng M, Tsai LH. Cyclin-dependent kinase 5 phosphorylates the N-terminal domain of the postsynaptic density protein PSD-95 in neurons. J Neurosci 2004; 24:865 - 76; http://dx.doi.org/10.1523/JNEUROSCI.4582-03.2004; PMID: 14749431
   PubMed Web of Science ®Google Scholar
• Zheng YL, Li BS, Amin ND, Albers W, Pant HC. A peptide derived from cyclin-dependent kinase activator (p35) specifically inhibits Cdk5 activity and phosphorylation of tau protein in transfected cells. Eur J Biochem 2002; 269:4427 - 34; http://dx.doi.org/10.1046/j.1432-1033.2002.03133.x; PMID: 12230554
   PubMedGoogle Scholar
• Huang YZ, Won S, Ali DW, Wang Q, Tanowitz M, Du QS, et al. Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses. Neuron 2000; 26:443 - 55; http://dx.doi.org/10.1016/S0896-6273(00)81176-9; PMID: 10839362
   PubMed Web of Science ®Google Scholar
• Ehlers MD, Zhang S, Bernhadt JP, Huganir RL. Inactivation of NMDA receptors by direct interaction of calmodulin with the NR1 subunit. Cell 1996; 84:745 - 55; http://dx.doi.org/10.1016/S0092-8674(00)81052-1; PMID: 8625412
   PubMed Web of Science ®Google Scholar
• Vulliet R, Halloran SM, Braun RK, Smith AJ, Lee G. Proline-directed phosphorylation of human Tau protein. J Biol Chem 1992; 267:22570 - 4; PMID: 1429606
   PubMed Web of Science ®Google Scholar
• Zhang P, Yu PC, Tsang AH, Chen Y, Fu AK, Fu WY, et al. S-nitrosylation of cyclin-dependent kinase 5 (cdk5) regulates its kinase activity and dendrite growth during neuronal development. J Neurosci 2010; 30:14366 - 70; http://dx.doi.org/10.1523/JNEUROSCI.3899-10.2010; PMID: 20980593
   PubMed Web of Science ®Google Scholar
• Cho DH, Seo J, Park JH, Jo C, Choi YJ, Soh JW, et al. Cyclin-dependent kinase 5 phosphorylates endothelial nitric oxide synthase at serine 116. Hypertension 2010; 55:345 - 52; http://dx.doi.org/10.1161/HYPERTENSIONAHA.109.140210; PMID: 20048197
   PubMed Web of Science ®Google Scholar
• Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, Sue L, et al. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer’s disease. Am J Pathol 1999; 155:853 - 62; http://dx.doi.org/10.1016/S0002-9440(10)65184-X; PMID: 10487842
   PubMed Web of Science ®Google Scholar
• McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, Beyreuther K, et al. Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer’s disease. Ann Neurol 1999; 46:860 - 6; http://dx.doi.org/10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; PMID: 10589538
   PubMed Web of Science ®Google Scholar
• Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, et al. Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991; 30:572 - 80; http://dx.doi.org/10.1002/ana.410300410; PMID: 1789684
   PubMed Web of Science ®Google Scholar
• Penzes P, Cahill ME, Jones KA, VanLeeuwen JE, Woolfrey KM. Dendritic spine pathology in neuropsychiatric disorders. Nat Neurosci 2011; 14:285 - 93; http://dx.doi.org/10.1038/nn.2741; PMID: 21346746
   PubMed Web of Science ®Google Scholar
• Meuer K, Suppanz IE, Lingor P, Planchamp V, Göricke B, Fichtner L, et al. Cyclin-dependent kinase 5 is an upstream regulator of mitochondrial fission during neuronal apoptosis. Cell Death Differ 2007; 14:651 - 61; http://dx.doi.org/10.1038/sj.cdd.4402087; PMID: 17218957
   PubMed Web of Science ®Google Scholar
• Cartoni R, Martinou JC. Role of mitofusin 2 mutations in the physiopathology of Charcot-Marie-Tooth disease type 2A. Exp Neurol 2009; 218:268 - 73; http://dx.doi.org/10.1016/j.expneurol.2009.05.003; PMID: 19427854
   PubMed Web of Science ®Google Scholar
• Lawson VH, Graham BV, Flanigan KM. Clinical and electrophysiologic features of CMT2A with mutations in the mitofusin 2 gene. Neurology 2005; 65:197 - 204; http://dx.doi.org/10.1212/01.wnl.0000168898.76071.70; PMID: 16043786
   PubMed Web of Science ®Google Scholar
• Züchner S, Mersiyanova IV, Muglia M, Bissar-Tadmouri N, Rochelle J, Dadali EL, et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet 2004; 36:449 - 51; http://dx.doi.org/10.1038/ng1341; PMID: 15064763
   PubMed Web of Science ®Google Scholar
• Alexander C, Votruba M, Pesch UE, Thiselton DL, Mayer S, Moore A, et al. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet 2000; 26:211 - 5; http://dx.doi.org/10.1038/79944; PMID: 11017080
   PubMed Web of Science ®Google Scholar
• Delettre C, Lenaers G, Griffoin JM, Gigarel N, Lorenzo C, Belenguer P, et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet 2000; 26:207 - 10; http://dx.doi.org/10.1038/79936; PMID: 11017079
   PubMed Web of Science ®Google Scholar
• Olichon A, Guillou E, Delettre C, Landes T, Arnaune-Pelloquin L, Emorine LJ, et al. Mitochondrial dynamics and disease, OPA1. Biochim Biophys Acta 2006; 1763:500-509.
   Google Scholar
• Waterham HR, Koster J, van Roermund CW, Mooyer PA, Wanders RJ, Leonard JV. A lethal defect of mitochondrial and peroxisomal fission. N Engl J Med 2007; 356:1736 - 41; http://dx.doi.org/10.1056/NEJMoa064436; PMID: 17460227
   PubMed Web of Science ®Google Scholar
• Wang X, Su B, Lee HG, Li X, Perry G, Smith MA, et al. Impaired balance of mitochondrial fission and fusion in Alzheimer’s disease. J Neurosci 2009; 29:9090 - 103; http://dx.doi.org/10.1523/JNEUROSCI.1357-09.2009; PMID: 19605646
   PubMed Web of Science ®Google Scholar
• Su SC, Tsai LH. Cyclin-dependent kinases in brain development and disease. Annu Rev Cell Dev Biol 2011; 27:465 - 91; http://dx.doi.org/10.1146/annurev-cellbio-092910-154023; PMID: 21740229
   PubMed Web of Science ®Google Scholar
• Patrick GN, Zukerberg L, Nikolic M, de la Monte S, Dikkes P, Tsai LH. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 1999; 402:615 - 22; http://dx.doi.org/10.1038/45159; PMID: 10604467
   PubMed Web of Science ®Google Scholar
• Paoletti P, Vila I, Rifé M, Lizcano JM, Alberch J, Ginés S. Dopaminergic and glutamatergic signaling crosstalk in Huntington’s disease neurodegeneration: the role of p25/cyclin-dependent kinase 5. J Neurosci 2008; 28:10090 - 101; http://dx.doi.org/10.1523/JNEUROSCI.3237-08.2008; PMID: 18829967
   PubMed Web of Science ®Google Scholar
• Schmidt HHW, Kelm M. Determination of nitrite and nitrate by the Griess reaction. In: Feelisch M, Stamler JS, eds. Methods in Nitric Oxide Research New York, NY John Wiley and Sons 1996:491-497.
   Google Scholar